We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Let’s face it – we humans love our pets. World pet markets are growing at a dramatic rate, with several countries witnessing higher-than-ever pet ownership and spending. Industry insiders attribute this growth to the humanization of pets. This means that more and more cultures now regard companion animals as beloved family members. Hence, there is a push to increase the standard of living for pets – including higher quality veterinary care products.
In fact, animal health spending is a $30 billion industry, growing at approximately 7% per year. While a significant portion of veterinary healthcare spending is spent on ensuring the health of livestock, there is a fast-growing segment for companion animal care.
What, you might ask, can a company like West do for this market?
Containment matters. Whether it’s for humans or animals, drug products require primary containment that is suited to the unique needs of the drug itself. Today we are seeing a significant trend in human drug development crossing over into animal drug development. Such therapies addressing auto-immune conditions, treatments for pain, cancer and even diabetes.
For example, Zoetis, a leading animal health care company, recently obtained European marketing authorization for Cytopoint™ (lokivetmab), the first mAb therapy for veterinary use. This once monthly injectable product is used to treat clinical signs of atopic dermatitis in dogs, including itching and inflammation. The drug targets and neutralizes canine interleukin-31 (cIL-31), a key protein involved in triggering itch in dogs. The drug is available in single dose vials containing 10, 20, 30 or 40 mg/kg.1
West has partnered with drug companies to provide veterinary care products for more than 10 years. Our products help to ensure the quality and efficacy of the drugs given to our companions. As this industry grows, we’ll continue to collaborate with animal health care companies to keep our pets healthy, comfortable and safe – just like one of the family. For more information contact a technical representative.
Recently, 16 of the interns from the 2019 West Ambassador Internship Program visited two West sites in Jersey Shore and Williamsport, Pennsylvania. As interns from the corporate headquarters, the tours of the two local manufacturing locations offered a unique perspective to contrast the corporate experience. During the Jersey Shore and Williamsport tours, the interns were given a different experience to visualize the making of the product itself.
Combination products open up new vistas when it comes to delivering innovative therapies to patients in need, but teams bringing these products to the market face a number of significant hurdles. Recent surveys conducted by West at workshops held in PA and AZ revealed some of our customers’ biggest challenges. This is the final of our three blogs focused on these challenges — and how West can help Simplify the Journey™ when it comes to developing a combination product.
West’s Kinston, NC facility was recently recognized with an Honorable Mention at the 2016 International Society for Pharmaceutical Engineering’s (ISPE) Facility of the Year Awards’ ceremony on June 7, 2016, in Bethesda, Maryland. The award acknowledged the West team’s creativity and innovation during the Ready-to-Sterilize (RS) Expansion project, which was completed in June 2015.
Electron-beam irradiation (<em>e-beam </em>- sometimes called beta irradiation) is a technique used commonly to sterilize pharmaceutical packaging products and medical devices. It operates by directing a continuous flow of electrons through the articles being sterilized. Transfer of energy from the e-beam breaks the chains of DNA in organisms, rendering them inactive, and the articles irradiated as sterile. It is used typically for Ready-to-Use (RU) vials and syringes comprising Daikyo Crystal Zenith® cyclic olefin polymer, and Daikyo PLASCAP® seal products.
The supply of sterile pharmaceutical closures into a filling line is an essential element of the production of parenteral drug products. In addition to sterilizable bags, West offers closures in aseptic transfer bags – referred to as “port bags” or “ported bags.” Port bags contain a “beta” port that is attached to the actual bag <strong>(Figure 1).</strong>
English
Chinese
